those patients whose rheumatoid arthritis appears to respond to gold may be encouraged to continue long-term therapy with maintenance doses , in view of the evidence of sustained efficacy in most patients and of the declining risk of adverse reactions after the first 12 months .
C0003873
rheumatoid arthritis
C0018026
gold